CLONDALKIN GROUP TO ACQUIRE THE PRINTED COMPONENTS BUSINESS OF CATALENT PHARMA SOLUTIONS
Clondalkin Group and Catalent Pharma Solutions today announced that Clondalkin has agreed to acquire the Printed Components business of Catalent. Terms of the transaction were not disclosed, and closing is subject to receipt of regulatory approval. In addition, at closing Clondalkin and Catalent will enter into a long-term supply agreement which ensures that Catalent will continue to be able to provide customers of its market-leading commercial packaging business with high-quality printed components. With annual sales in excess of $100 million (€75 million), Printed Components manufactures
